{
    "code": "02014896",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02014896",
    "time": "2020-02-25 10:50:27",
    "許可證字號": "衛署藥輸字第014896號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/08\/16",
    "註銷理由": "屆期未申請展延",
    "製造許可登錄編號": "",
    "有效日期": "92\/09\/04",
    "發證日期": "75\/03\/20",
    "許可證種類": "製　劑",
    "舊證字號": "02002962",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201489602",
    "中文品名": "司特吉朗膠囊",
    "英文品名": "STUGERON FORTE CAPSULES",
    "適應症": "末梢血管循環障礙",
    "劑型": "130膠囊劑",
    "包裝": "盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CINNARIZINE",
    "限制項目": "02輸　入",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "申請商地址": "台北巿敦化南路２段３１９號３、４、５樓",
    "主製造廠": [
        {
            "製造廠名稱": "FBE0009000  JANSSEN PHARMACEUTICA N.V.",
            "製造廠廠址": "TURNHOUTSEWEG 30 B-2340 BEERSE",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0400000900",
            "成分名稱": "CINNARIZINE",
            "含量描述": "(R516) 75",
            "含量": "",
            "單位": "MG"
        }
    ]
}